Safety Alerts & Recalls
What does this mean?
This recall for Compro suppositories, USP 25 mg was issued at a warehouse/retail level only, with the FDA and the manufacturer determining that product already dispensed to patients does not pose a significant health risk. However, if you have Compro 25 mg suppositories labeled with these lot numbers and are concerned, you should consult with your physician.
Paddock Recalls Select Lots of Compro Prochlorperazine Suppositories At Warehouse/Retail Level
Paddock Laboratories, Inc. is recalling two lots of Compro prochlorperazine suppositories, USP 25 mg. Lot numbers 9116177 and 8172830 are being recalled because samples from these lots failed tests that measured their ability to dissolve.
Compro contains the active ingredient prochlorperazine and is most commonly used to prevent and treat nausea and vomiting. This recall alert only applies these two lots of Compro 25 mg Suppositories. No other Compro or prochlorperazine products are involved in this recall.
To view the FDA notice about this recall, please visit: more information here